8-K current report · filed Jun 29, 2026

UNITED THERAPEUTICS Corp (UTHR) 8-K Current Report: June 29, 2026

Item 5.07UTHR overview

Short answer

UNITED THERAPEUTICS Corp (UTHR) filed an 8-K current report with the SEC on June 29, 2026 reporting Item 5.07 (Submission of Matters to a Vote of Security Holders). All 12 director nominees elected for one-year terms, with support ranging from 89.3% to 99.9% of votes cast.

UNITED THERAPEUTICS Corp 8-K event analysis

AI summary of each reported item and its exhibits

Item 5.07 · Submission of Matters to a Vote of Security Holders

  • All 12 director nominees elected for one-year terms, with support ranging from 89.3% to 99.9% of votes cast
  • Kevin Tracey received strongest director support: 36,187,554 votes for and 18,239 against
  • Executive compensation advisory vote approved decisively, 35,152,059 for versus 1,048,505 against
  • 2026 Stock Incentive Plan approved narrowly, with 25,872,075 for versus 10,070,290 against
  • Ernst & Young LLP ratified as 2026 auditor, 35,753,887 votes for versus 1,647,415 against

Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean

Other UNITED THERAPEUTICS Corp 8-K filings

Get the next UTHR 8-K as it lands

Follow UTHR for push alerts, or ask the research agent what this filing means.